Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Stocktwits
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
KnowBe4 Research Reveals a Confidence Gap in Cybersecurity, Leaving Organizations at Risk
March 11, 2025
From
KnowBe4, Inc.
Via
GlobeNewswire
Rezolve Ai to Present at 37th Annual Roth Conference March 16-18, 2025
March 11, 2025
From
Rezolve AI Ltd
Via
GlobeNewswire
Tickers
RZLV
GCL Announces Upcoming Release Date for ‘JDM: Japanese Drift Master’
March 11, 2025
From
GCL Global Holdings Ltd.
Via
GlobeNewswire
Tickers
GCL
ACV Announces Transfer of Listing of Common Stock to the New York Stock Exchange
March 11, 2025
From
ACV
Via
GlobeNewswire
Tickers
ACVA
Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital
March 11, 2025
From
Alzamend Neuro, Inc.
Via
GlobeNewswire
Tickers
ALZN
AVID Partners with Super League to Launch Educational Experience on Roblox Focused on Executive Function and Durable Skills
March 11, 2025
From
Super League Enterprise
Via
GlobeNewswire
Tickers
SLE
Brera Holdings Hosts Inaugural Investor Weekend at its Italian Serie B Football Club Juve Stabia, 'The Second Team of Naples,' Showcasing Sport, Culture, and Strategic Growth
March 11, 2025
From
Brera Holdings PLC
Via
GlobeNewswire
Tickers
BREA
360 Privacy Secures $36 Million Growth Investment from FTV Capital
March 11, 2025
From
360 Privacy
Via
GlobeNewswire
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
March 11, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
PharmaTher Receives US FDA Approval Goal Date for Ketamine
March 11, 2025
From
PharmaTher Holdings Ltd.
Via
GlobeNewswire
Tickers
CSE:PHRM
PHRRF
Armlogi Holding Corp. Reports 20% Workforce Expansion Since Mid-2023
March 11, 2025
From
Armlogi Holding Corp
Via
GlobeNewswire
Tickers
BTOC
Jeffs’ Brands Enters Into a Definitive Agreement to Acquire a U.S. Company that Operates a U.S. Based Logistics Center, aiming to Advance its Growth Strategy, for $2.6 million
March 11, 2025
From
Jeffs' Brands Ltd
Via
GlobeNewswire
Tickers
JFBR
JFBRW
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
FuelCell Energy Reports First Quarter of Fiscal 2025 Results
March 11, 2025
From
FuelCell Energy, Inc.
Via
GlobeNewswire
Tickers
FCEL
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
March 11, 2025
From
Biogen Inc.
Via
GlobeNewswire
Tickers
BIIB
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
March 11, 2025
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DYN
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
March 11, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
March 11, 2025
From
ProMIS Neurosciences Inc.
Via
GlobeNewswire
Tickers
PMN
TORRAS Powers Ahead in 2025: Building a Robust Low-Temperature Charging Ecosystem
March 11, 2025
From
TORRAS
Via
GlobeNewswire
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
March 11, 2025
From
Aurora Spine Corporation
Via
GlobeNewswire
Tickers
ASAPF
TSX-V:ASG
Gauzy Ltd. Announces Record Fourth Quarter and Full Year 2024 Results
March 11, 2025
From
GAUZY LTD
Via
GlobeNewswire
Tickers
GAUZ
ECARX Announces Fourth Quarter and Full Year 2024 Unaudited Financial Results
March 11, 2025
From
ECARX LIMITED
Via
GlobeNewswire
Tickers
ECX
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
March 11, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Tickers
LEGN
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 11, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 11, 2025
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
PyroGenesis and GE Vernova Sign Memorandum of Understanding (MOU)
March 11, 2025
From
PyroGenesis Inc.
Via
GlobeNewswire
Tickers
GEV
PYRGF
TSX:PYR
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
March 11, 2025
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
Second Trader in Axi’s Capital Allocation Program, Axi Select, Secures $1,000,000 in Funding
March 11, 2025
From
AxiTrader Limited
Via
GlobeNewswire
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
March 11, 2025
From
Matinas BioPharma Holdings, Inc.
Via
GlobeNewswire
Tickers
GRCE
ONVO
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.